Journal Watch · Genome Biology · 2026

FIRST-seq: a nanopore-based cDNA sequencing platform for RNA modification and structure profiling.

FIRST-seq offers a versatile platform for profiling chemical-induced and natural RNA modifications using long-read sequencing.

Begik O, Diensthuber G, Borovska I et al.Genome Biology3 min readPharma relevance 30/100

DOI: 10.1186/s13059-026-04115-wPMID: 42218558Study type: in-vitro / cell study

TL;DR

FIRST-seq offers a versatile platform for profiling chemical-induced and natural RNA modifications using long-read sequencing.

Key findings

  • FIRST-seq offers a versatile platform for profiling chemical-induced and natural RNA modifications using long-read sequencing.

What they did

Benchmarking multiple RT enzymes and buffers identified conditions that reduce premature termination and enhance error detection. Coupled with DMS probing, FIRST-seq accurately detects m1A and m3C at unpaired sites, recapitulating known RNA structures in vitro and in vivo.

Full abstract (original)

Background: RNA modifications induce reverse transcription (RT) errors in an enzyme- and context-dependent manner, enabling transcriptome-wide mapping and RNA structure probing. We present FIRST-seq, a flexible, cost-effective nanopore cDNA method that avoids second-strand synthesis and PCR, making it compatible with any RT enzyme and enabling single-nucleotide resolution RT signature analysis.

What they did: Benchmarking multiple RT enzymes and buffers identified conditions that reduce premature termination and enhance error detection. Coupled with DMS probing, FIRST-seq accurately detects m1A and m3C at unpaired sites, recapitulating known RNA structures in vitro and in vivo.

Results & conclusions: FIRST-seq offers a versatile platform for profiling chemical-induced and natural RNA modifications using long-read sequencing.

Abstract © the authors / Genome Biology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1186/s13059-026-04115-w · PubMed 42218558.

Why it matters for pharma & biotech

  • Relevant to Biology & Life Sciences teams tracking Genome Biology for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Genome Biology study find?

FIRST-seq offers a versatile platform for profiling chemical-induced and natural RNA modifications using long-read sequencing.

What type of study is this?

It is a in-vitro / cell study, published in Genome Biology in 2026. Benchmarking multiple RT enzymes and buffers identified conditions that reduce premature termination and enhance error detection.

Where can I read the original paper?

The original is at the publisher via DOI 10.1186/s13059-026-04115-w. PubMed ID: 42218558. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Begik O, Diensthuber G, Borovska I et al.. FIRST-seq: a nanopore-based cDNA sequencing platform for RNA modification and structure profiling.. Genome Biology (2026). DOI: 10.1186/s13059-026-04115-w.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/first-seq-a-nanopore-based-cdna-sequencing-platform-for-rna-modification-04115w/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides